Search hospitals > Michigan > Detroit
Children's Hospital of Michigan
Claim this profileDetroit, Michigan 48201
Global Leader in Human Immunodeficiency Virus Infection
Global Leader in Leukemia
Conducts research for Brain Tumor
Conducts research for Sickle Cell Anemia
Conducts research for Tumors
309 reported clinical trials
18 medical researchers
Summary
Children's Hospital of Michigan is a medical facility located in Detroit, Michigan. This center is recognized for care of Human Immunodeficiency Virus Infection, Leukemia, Brain Tumor, Sickle Cell Anemia, Tumors and other specialties. Children's Hospital of Michigan is involved with conducting 309 clinical trials across 427 conditions. There are 18 research doctors associated with this hospital, such as Jeffrey Taub, MD, Roland L. Chu, Alissa M. Martin, and Meret Henry, MD.Area of expertise
1Human Immunodeficiency Virus Infection
Global Leader2Leukemia
Global LeaderBCR-ABL1 fusion positive
ABL-class fusion positive
FLT3 negative
Top PIs
Jeffrey Taub, MDWayne State University/Karmanos Cancer Institute6 years of reported clinical research
Studies Lymphoma
Studies Brain Tumor
13 reported clinical trials
55 drugs studied
Roland L. ChuChildren's Hospital of Michigan7 years of reported clinical research
Studies Neuroblastoma
Studies Ganglioneuroblastoma
8 reported clinical trials
24 drugs studied
Alissa M. MartinChildren's Hospital of Michigan4 years of reported clinical research
Studies Tumors
Studies Cancer
8 reported clinical trials
34 drugs studied
Meret Henry, MDChildren's Hospital of Michigan7 years of reported clinical research
Studies Leukemia
Studies Lymphoma
7 reported clinical trials
36 drugs studied
Clinical Trials running at Children's Hospital of Michigan
Rhabdomyosarcoma
Brain Tumor
Acute Lymphoblastic Leukemia
Germ Cell Tumors
Osteosarcoma
Leukemia
Acute Myeloid Leukemia
Myelodysplastic Syndrome
Lymphoblastic Leukemia-Lymphoma
Ovarian Tumors
Combination Chemotherapy
for Rhabdomyosarcoma
This study is evaluating whether a combination of chemotherapy drugs is more effective than a single chemotherapy drug for treating rhabdomyosarcoma.
Recruiting2 awards Phase 35 criteria
Chemotherapy
for Rhabdomyosarcoma
Rhabdomyosarcoma is a type of cancer that occurs in the soft tissues in the body. This phase III trial aims to maintain excellent outcomes in patients with very low risk rhabdomyosarcoma (VLR-RMS) while decreasing the burden of therapy using treatment with 24 weeks of vincristine and dactinomycin (VA) and examines the use of centralized molecular risk stratification in the treatment of rhabdomyosarcoma. Another aim of the study it to find out how well patients with low risk rhabdomyosarcoma (LR-RMS) respond to standard chemotherapy when patients with VLR-RMS and patients who have rhabdomyosarcoma with DNA mutations get separate treatment. Finally, this study examines the effect of therapy intensification in patients who have RMS cancer with DNA mutations to see if their outcomes can be improved.
Recruiting2 awards Phase 3
Genetic Testing-Directed Therapy
for Pediatric Cancer
This study is evaluating whether genetic testing may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Children's Hospital of Michigan?
Children's Hospital of Michigan is a medical facility located in Detroit, Michigan. This center is recognized for care of Human Immunodeficiency Virus Infection, Leukemia, Brain Tumor, Sickle Cell Anemia, Tumors and other specialties. Children's Hospital of Michigan is involved with conducting 309 clinical trials across 427 conditions. There are 18 research doctors associated with this hospital, such as Jeffrey Taub, MD, Roland L. Chu, Alissa M. Martin, and Meret Henry, MD.